Quanterix Corporation has announced a significant leadership change with the resignation of Everett Cunningham as President and Chief Executive Officer, effective immediately. Cunningham has accepted another opportunity in the healthcare sector, and his departure is not related to any disagreements with the company. In light of this transition, the board has appointed James Gute, the current Chief Commercial Officer, as the Interim President and CEO while they search for a permanent replacement.
This leadership shift is crucial for Quanterix as it continues to navigate the competitive landscape of laboratory analytical instruments. The company is expected to maintain its focus on its business outlook, reaffirming its financial targets for 2026.
According to the SEC filing dated November 18, 2026, Cunningham will assist with the transition until December 11, 2026. The board has engaged an executive search firm to find a new CEO, considering both internal and external candidates. Gute, who joined Quanterix in August 2026, has a robust background in commercial leadership, previously holding senior roles at Exact Sciences and GE Healthcare.
The filing states, "Pending the Board's search for a permanent President and Chief Executive Officer, the Company has appointed James Gute... to serve as the Company’s Interim President and Chief Executive Officer, effective November 18, 2026." Gute's interim salary will be set at $750,000 annually.
Quanterix, known for its precision biomarker science, is well-positioned to capitalize on opportunities in the industry. The board expressed confidence in Gute's ability to lead the company during this transitional period. Bill Donnelly, Chair of the Board, stated, "Jim is highly regarded within Quanterix and, with his experience leading successful commercial teams... he is well equipped to take on the additional role of Interim CEO."
As Quanterix moves forward, it aims to enhance its commercial execution and accelerate revenue growth. The company has a strong balance sheet and several exciting catalysts on the horizon, which will be critical as it seeks to strengthen its position in the market.
In summary, the leadership transition at Quanterix Corp marks a pivotal moment for the company as it seeks to maintain momentum in the laboratory analytical instruments sector. The board's proactive approach in appointing an interim CEO and searching for a permanent leader reflects its commitment to ensuring continuity and growth.
Read Next
Sven-Olof Lindblad sells shares in Lindblad Expeditions
Zeo Energy CEO Timothy Bridgewater Acquires 107,955 Shares
Manthripragada Vijay Acquires Additional Shares in Onterris
Laws James Acquires Shares in Onterris, Inc. via RSUs
Eightco Holdings CEO Acquires 100,000 Shares of Stock
Eightco CFO Vroman Acquires 15,000 Shares in Stock Transaction





